| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 174,211 | 2,279 |
| Net (decrease) increase in cash and cash equivalents | -15,810 | -14,338 |
| Cash and cash equivalents at beginning of period | 38,344 | - |
| Cash and cash equivalents at end of period | 22,534 | - |
ASSEMBLY BIOSCIENCES, INC. (ASMB)
ASSEMBLY BIOSCIENCES, INC. (ASMB)